A Literature Review of Major Clinical Trials That Contributed to Treatment Protocols of Irritable Bowel Syndrome With Diarrhea
Open Access
- 19 June 2022
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26092
Abstract
The most common reason for seeing a gastroenterologist is irritable bowel syndrome (IBS). IBS was thought to be a functional disease; however, there are now numerous alternative pathophysiologic pathways that can explain the symptoms. The pathophysiology of IBS is diverse and not well understood. Most current first-line treatments for IBS target the primary symptom and mainly impact one symptom in the symptom complex. The purpose of this study was to summarize the data on new medicines used to treat IBS. We conducted a bibliographic search in Google Scholar and PubMed focused on medication clinical trials in IBS with diarrhea. New medications for IBS with diarrhea target important pathways in the pathophysiology of these disorders, improving both the abnormal bowel habit and other significant symptoms such as abdominal pain and bloating.Keywords
This publication has 5 references indexed in Scilit:
- Irritable bowel syndrome: the clinical approachPanminerva Medica, 2018
- The role of inflammation in irritable bowel syndrome (IBS)Journal of Inflammation Research, 2018
- New treatments and therapeutic targets for IBS and other functional bowel disordersNature Reviews Gastroenterology & Hepatology, 2018
- Medication Management of Irritable Bowel SyndromeDigestion, 2014
- Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysisEuropean Archives of Psychiatry and Clinical Neuroscience, 2014